Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,870.00
Bid: 3,865.00
Ask: 3,875.00
Change: -20.00 (-0.51%)
Spread: 10.00 (0.259%)
Open: 3,900.00
High: 3,925.00
Low: 3,870.00
Prev. Close: 3,890.00
RSW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

26 Oct 2023 07:00

RNS Number : 3073R
Renishaw PLC
26 October 2023
 

Renishaw plc

Trading update

26 October 2023

 

 

Steady recent performance in challenging market conditions

Renishaw plc, the global provider of manufacturing technologies, analytical instruments and medical devices, publishes this trading update for the three months ended 30 September 2023. It contains unaudited information that covers the first quarter of the financial year and the period since.

 

Trading activity

 

 

3 months to 30 September 2023

3 months to 30 September 2022

Change

 

 

 

 

Manufacturing technologies

£156.8m

£172.8m

-9%

Analytical instruments and medical devices

£7.7m

£7.1m

+8%

Total revenue

£164.5m

£179.9m

-9%

Total revenue at FY2023 exchange rates

£169.6m

£179.9m

-6%

 

 

 

Adjusted* profit before tax

£28.0m

£40.0m

-30%

Statutory profit before tax

£28.0m

£38.6m

-27%

 

Revenue was £164.5m, compared to £179.9m for the corresponding period last year, representing a 9% reduction and a 6% reduction at constant currency. All regions experienced reduced demand compared to Q1 FY2023. Whilst there was modest growth for the Industrial Metrology area of our business, revenues for our Position Measurement products were substantially below a strong period last year. However, compared to Q4 FY2023, revenue was 1% lower at constant currency, with no significant changes to market conditions.

 

In our Manufacturing technologies business, revenue amounted to £156.8m, compared to £172.8m last year. Revenue for our Analytical instruments and medical devices business was £7.7m, an increase of 8% compared with £7.1m last year.

 

Adjusted profit before tax for the first quarter amounted to £28.0m (FY2023: £40.0m) and was 4% lower than the final quarter of the previous financial year. Statutory profit before tax amounted to £28.0m (FY2023: £38.6m).

 

Financial position

The Group balance sheet remains strong with net cash and cash equivalents and bank deposit balances of £206.7m at 30 September 2023 (30 June 2023: £206.4m).

 

Outlook

Trading conditions remain challenging due to subdued demand, most notably from the semiconductor sector. We continue to see positive investment trends in robotics, defence, low emission transportation and additive manufacturing.

 

We continue to carefully manage costs, implement targeted price rises and focus on productivity improvements.

 

Our investments in product innovation, infrastructure, and people leave us well-positioned to benefit from a recovery in our markets. We are confident in our strategy to deliver sustainable long-term growth.

The results for the half year ending 31 December 2023 will be released on 6 February 2024.

 

Will Lee

Allen Roberts

 

Chief Executive

Group Finance Director

 

 

26 October 2023

 

 

Renishaw plc

Registered office

New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number

01106260

Telephone number

+44 (0) 1453 524524

Website

www.renishaw.com

 

 

 

 

* The adjustment to statutory profit relates to the accounting treatment of certain forward currency contracts used as hedging instruments which do not qualify for hedge accounting as they do not meet the hedge effectiveness criteria set out in the International Accounting Standard IFRS 9 'Financial Instruments'. The Board deems that the adjusted profit before tax also represents a useful measure of performance of the Group. All previously ineffective contracts matured in FY2023 and no further contracts have been designated as ineffective in FY2024. The following table reconciles statutory profit before tax to adjusted profit before tax:

 

£'m

3 months to 30 September 2023

3 months to 30 September 2022

 

£'000

£'000

 

 

Statutory profit before tax

28.0

38.6

 

 

Fair value (gains)/losses on financial instruments not eligible for hedge accounting

 

- reported in revenue

-

(3.7)

- reported in (gains)/losses from the fair value of financial instruments

-

5.1

 

 

Adjusted profit before tax

28.0

40.0

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEASESASKDFFA
Date   Source Headline
17th Dec 20123:45 pmRNSDirector/PDMR Shareholding
8th Nov 20127:42 amRNSDirector/PDMR Shareholding
31st Oct 20129:49 amRNSStatement re shareholders voting agreement
22nd Oct 201210:13 amRNSDirector/PDMR Shareholding
18th Oct 20122:11 pmRNSResult of AGM
18th Oct 201210:30 amRNSInterim Management Statement
10th Oct 20127:22 amRNSDirectorate Change
20th Sep 201212:13 pmRNSDirector Declaration
13th Sep 20123:27 pmRNSDirector/PDMR Shareholding
24th Aug 20128:47 amRNSAnnual Report and Accounts 2012 and Notice of AGM
2nd Aug 20127:53 amRNSDirector/PDMR Shareholding
25th Jul 20127:00 amRNSFinal Results
23rd Jul 20121:19 pmRNSNotice of Results
15th May 20127:00 amRNSInterim Management Statement
10th May 20121:26 pmRNSStatement re date of Interim Management Statement
25th Apr 201212:48 pmRNSDirectorate Change
16th Apr 20122:08 pmRNSDirector/PDMR Shareholding
25th Jan 20127:00 amRNSHalf Yearly Report
12th Dec 20111:44 pmRNSHolding(s) in Company
24th Oct 20118:17 amRNSDirector/PDMR Shareholding
13th Oct 20112:19 pmRNSResult of AGM
13th Oct 201111:26 amRNSHolding(s) in Company
13th Oct 201111:05 amRNSInterim Management Statement
7th Sep 20113:56 pmRNSAnnual Information Update
19th Aug 20118:56 amRNSAnnual Financial Report
12th Aug 20119:02 amRNSDirector/PDMR Shareholding
27th Jun 20111:30 pmRNSFacilities expansion plans
23rd Jun 201112:09 pmRNSHolding(s) in Company
17th May 20117:00 amRNSInterim Management Statement
26th Apr 20119:53 amRNSDirector/PDMR Shareholding
16th Mar 20113:17 pmRNSHolding(s) in Company
26th Jan 20117:00 amRNSHalf Yearly Report
24th Dec 20109:35 amRNSDirector/PDMR Shareholding
14th Oct 20102:29 pmRNSResult of AGM
14th Oct 201010:37 amRNSInterim Management Statement
9th Sep 20107:00 amRNSTrading Statement
1st Sep 20101:15 pmRNSAnnual Information Update
23rd Aug 20107:00 amRNSAnnual Financial Report
28th Jul 20107:00 amRNSFinal Results
23rd Jun 20101:51 pmRNSHolding(s) in Company - Replacement
23rd Jun 20101:50 pmRNSHolding(s) in Company - Replacement
23rd Jun 20101:43 pmRNSDirector/PDMR Shareholding
23rd Jun 20101:39 pmRNSDirector/PDMR Shareholding - Replacement
22nd Jun 201011:52 amRNSHolding(s) in Company
22nd Jun 201011:51 amRNSHolding(s) in Company
22nd Jun 201011:49 amRNSDirector/PDMR Shareholding
22nd Jun 201011:46 amRNSDirector/PDMR Shareholding
21st Jun 20105:32 pmRNSHolding(s) in Company
21st Jun 20105:23 pmRNSDirector/PDMR Shareholding
17th May 20109:32 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.